Skip to main content

Sedentary Behavior

0
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Verona Pharma
Verona PharmaUK - London
1 program
Echolgical physical activity InterventionN/A1 trial
Active Trials
NCT04877938Unknown180Est. Feb 2023
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Participatory interventionN/A1 trial
Active Trials
NCT04679246Completed3,000Est. Nov 2018
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Reduced ActivityN/A1 trial
Active Trials
NCT04137068Unknown20Est. Mar 2023
Jerusalem Pharmaceuticals
Jerusalem PharmaceuticalsIsrael - Ramallah
1 program
leadership empowermentN/A1 trial
Active Trials
NCT04500977Unknown150Est. Dec 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Verona PharmaEcholgical physical activity Intervention
Oregon TherapeuticsReduced Activity
Jerusalem Pharmaceuticalsleadership empowerment
Human BioSciencesParticipatory intervention

Clinical Trials (4)

Total enrollment: 3,350 patients across 4 trials

NCT04877938Verona PharmaEcholgical physical activity Intervention

ACTLIFE: is Active Life-style Enough?

Start: Jun 2021Est. completion: Feb 2023180 patients
N/AUnknown

Sedentary Behavior, Cardiovascular Function, and Sleep

Start: Nov 2019Est. completion: Mar 202320 patients
N/AUnknown

Training Health Promotion Women Community Leaders

Start: Sep 2018Est. completion: Dec 2025150 patients
N/AUnknown
NCT04679246Human BioSciencesParticipatory intervention

Participatory Intervention to Improve Nutrition and Physical Activity in Schoolchildren From Acatlán de Juárez, Jalisco

Start: May 2015Est. completion: Nov 20183,000 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.